CSS
PVLA

Cubist Systematic Strategies’s Palvella Therapeutics PVLA Stock Holding History

Cubist Systematic Strategies’s Portfolio PVLA Stock Details PVLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-218
Closed -$33K – 4789
2022
Q2 		$33K Sell
218
-2,230
-91% -$407K ﹤0.01% 4163
2022
Q1 		$593K Sell
2,448
-727
-23% -$191K 0.01% 2424
2021
Q4 		$960K Sell
3,175
-2,229
-41% -$714K 0.01% 1948
2021
Q3 		$2.23M Buy
5,404
+4,871
+914% +$1.7M 0.03% 937
2021
Q2 		$163K Buy
+533
New +$117K ﹤0.01% 2627
2020
Q1 		– Sell
-279
Closed -$81K – 2513
2019
Q4 		$81K Buy
+279
New +$77.3K ﹤0.01% 2226
2019
Q3 		– Sell
-48
Closed -$18K – 2533
2019
Q2 		$18K Buy
48
+29
+153% +$8.65K ﹤0.01% 2385
2019
Q1 		$5K Sell
19
-133
-88% -$31.6K ﹤0.01% 2206
2018
Q4 		$32K Buy
+152
New +$47.1K ﹤0.01% 1920
2018
Q3 		– Sell
-393
Closed -$160K – 2117
2018
Q2 		$160K Sell
393
-124
-24% -$59K 0.01% 1430
2018
Q1 		$282K Buy
517
+367
+245% +$227K 0.02% 1190
2017
Q4 		$90K Buy
+150
New +$69.7K ﹤0.01% 1698

Other funds holding PVLA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Cubist Systematic Strategies's PVLA Position: Q3 2022 in Review

Cubist Systematic Strategies sold out of Palvella Therapeutics (PVLA) in Q3 2022, closing a stake of 218 shares — an estimated $33K sold.

Cubist Systematic Strategies first reported a position in PVLA in Q4 2017 and held it in 12 quarters. The position peaked at $2.23M in Q3 2021. 65 funds tracked by Wall St. Rank hold PVLA as of Q3 2022.

  • Cubist Systematic Strategies reported no remaining Palvella Therapeutics position as of Q3 2022 after selling out during the quarter.
  • Cubist Systematic Strategies sold 218 Palvella Therapeutics shares in Q3 2022, an estimated $33K.
  • Cubist Systematic Strategies first reported a position in Palvella Therapeutics in Q4 2017 and held it in 12 quarters.
  • Cubist Systematic Strategies's Palvella Therapeutics position peaked at $2.23M in Q3 2021.
  • 65 funds tracked by Wall St. Rank held Palvella Therapeutics as of Q3 2022.

Based on Cubist Systematic Strategies's 13F filing for Q3 2022, filed 14 Nov 2022.